Home › Funds › Redmile Group, LLC › STOK

Redmile Group, LLC position in STOK

STOKE THERAPEUTICS INC · Health Care

Redmile Group, LLC reported holding 3,945,920 shares of STOK (STOKE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$129.1M, representing 8.67% of its reported portfolio and ranking #3 among its reported holdings. Redmile Group, LLC has disclosed STOK holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)3.95M sh
Reported value held$129.11M
Portfolio Weight8.67%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Redmile Group, LLC's STOK position evolved

Redmile Group, LLC first disclosed a stake in STOK in Q3 2023 at 3,872,696 shares (US$15.3M). The position peaked in Q1 2026 at 4,164,120 shares, worth US$135.6M. Across 12 filings, Redmile Group, LLC increased the stake 2 time(s), trimmed it 8 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 3,945,920 shares valued at US$129.1M — a reduction of -218,200 shares quarter over quarter.. Notable position changes include a 32% trim in Q4 2023 (shares rose 157% over the following quarter), a 93% increase in Q1 2024 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.87M $15.26M New
Q4 2023 2.63M $13.81M Reduce
Q1 2024 5.07M $68.49M Add
Q2 2024 4.72M $63.78M Reduce
Q3 2024 4.71M $57.93M Hold
Q4 2024 4.59M $50.67M Reduce
Q1 2025 4.49M $29.83M Reduce
Q2 2025 4.38M $49.67M Reduce
Q3 2025 4.18M $98.13M Reduce
Q4 2025 4.03M $128.04M Reduce
Q1 2026 4.16M $135.58M Add
Q2 2026 3.95M $129.11M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About STOK and 13F data

STOK (STOKE THERAPEUTICS INC) is a Health Care company. 52 other funds we track also report a position in STOK — the largest reported positions include RTW INVESTMENTS, LP (US$184.0M), Lynx1 Capital Management LP (US$132.1M), BAKER BROS. ADVISORS LP (US$109.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding STOK

All STOK fund holders →

FAQ

How long has Redmile Group, LLC held STOK?

Redmile Group, LLC has disclosed STOK holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Redmile Group, LLC's current position in STOK?

As of Q2 2026, Redmile Group, LLC holds 3.95M shares of STOK (STOKE THERAPEUTICS INC), valued at $129.11M, representing 8.67% of its reported portfolio and ranking #3.

Has Redmile Group, LLC been buying or selling STOK?

In the latest 13F filing (Q2 2026), Redmile Group, LLC reduced its position in STOK. The position peaked in Q1 2026 at 4.16M shares.

Which other funds hold STOK?

Other major institutional holders of STOK include RTW INVESTMENTS, LP, Lynx1 Capital Management LP, BAKER BROS. ADVISORS LP, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.